Sphera Funds Management Ltd. Eiger Bio Pharmaceuticals, Inc. Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$8.3 - $16.8 $3.94 Million - $7.98 Million	-475,000 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$8.1 - $16.0 $295,398 - $583,504	-36,469 Reduced 7.13%	475,000 $4.68 Million
Q4 2017 Feb 12, 2018	SELL	$10.5 - $14.15 $92,400 - $124,520	-8,800 Reduced 1.69%	511,469 $7.14 Million
Q3 2017 Nov 09, 2017	BUY	$7.7 - $11.55 $4.01 Million - $6.01 Million	520,269	520,269 $5.72 Million

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $496M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.